Trial Outcomes & Findings for Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years (NCT NCT03562481)

NCT ID: NCT03562481

Last Updated: 2020-06-25

Results Overview

Perceived pain on injection, self-reported verbally using a Likert scale from 1-10, with lower numbers corresponding to less pain (1 = "no pain," 10 = "worst pain imaginable"). Lower scores reflect a lesser degree of pain.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

26 participants

Primary outcome timeframe

Within 10 minutes of injection

Results posted on

2020-06-25

Participant Flow

Participant milestones

Participant milestones
Measure
Sequence 1: Unbuffered Anesthetic, Then Buffered Anesthetic
Subjects randomized to Unbuffered Anesthetic, then Buffered Anesthetic will first receive an injection with 2% Unbuffered Lidocaine 1:100,000 Epinephrine. 1% After one week minimum washout period, subjects will then receive an injection with Buffered Lidocaine 1:100,000 Epinephrine.
Sequence 2: Buffered Anesthetic, Then Unbuffered Anesthetic
Subjects randomized to Buffered Anesthetic, then Unbuffered Anesthetic will first receive an injection with 1% Buffered Lidocaine 1:100,000 Epinephrine. After one week minimum washout period, subjects will then receive an injection with 2% Unbuffered Lidocaine 1:100,000 Epinephrine.
First Intervention
STARTED
12
14
First Intervention
COMPLETED
11
14
First Intervention
NOT COMPLETED
1
0
Washout
STARTED
11
14
Washout
COMPLETED
11
14
Washout
NOT COMPLETED
0
0
Second Intervention
STARTED
11
14
Second Intervention
COMPLETED
11
14
Second Intervention
NOT COMPLETED
0
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Sequence 1: Unbuffered Anesthetic, Then Buffered Anesthetic
Subjects randomized to Unbuffered Anesthetic, then Buffered Anesthetic will first receive an injection with 2% Unbuffered Lidocaine 1:100,000 Epinephrine. 1% After one week minimum washout period, subjects will then receive an injection with Buffered Lidocaine 1:100,000 Epinephrine.
Sequence 2: Buffered Anesthetic, Then Unbuffered Anesthetic
Subjects randomized to Buffered Anesthetic, then Unbuffered Anesthetic will first receive an injection with 1% Buffered Lidocaine 1:100,000 Epinephrine. After one week minimum washout period, subjects will then receive an injection with 2% Unbuffered Lidocaine 1:100,000 Epinephrine.
First Intervention
Lost to Follow-up
1
0

Baseline Characteristics

Clinical Trial Comparing Effectiveness of Buffered Versus Unbuffered Local Anesthetic in Children Ages 10-12 Years

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Sequence 1: Unbuffered Anesthetic, Then Buffered Anesthetic
n=12 Participants
Subjects randomized to Unbuffered Anesthetic, then Buffered Anesthetic will first receive an injection with 2% Unbuffered Lidocaine 1:100,000 Epinephrine. After one week minimum washout period, subjects will then receive an injection with 1% Buffered Lidocaine 1:100,000 Epinephrine.
Sequence 2: Buffered Anesthetic, Then Unbuffered Anesthetic
n=14 Participants
Subjects randomized to Buffered Anesthetic, then Unbuffered Anesthetic will first receive an injection with 1% Buffered Lidocaine 1:100,000 Epinephrine. After one week minimum washout period, subjects will then receive an injection with 2% Unbuffered Lidocaine 1:100,000 Epinephrine.
Total
n=26 Participants
Total of all reporting groups
Age, Continuous
11.5 years
STANDARD_DEVIATION 0.5 • n=99 Participants
10.9 years
STANDARD_DEVIATION 0.9 • n=107 Participants
11.2 years
STANDARD_DEVIATION 0.8 • n=206 Participants
Sex: Female, Male
Female
4 Participants
n=99 Participants
9 Participants
n=107 Participants
13 Participants
n=206 Participants
Sex: Female, Male
Male
8 Participants
n=99 Participants
5 Participants
n=107 Participants
13 Participants
n=206 Participants
Race/Ethnicity, Customized
Asian
1 Participants
n=99 Participants
0 Participants
n=107 Participants
1 Participants
n=206 Participants
Race/Ethnicity, Customized
Black
4 Participants
n=99 Participants
1 Participants
n=107 Participants
5 Participants
n=206 Participants
Race/Ethnicity, Customized
White
7 Participants
n=99 Participants
12 Participants
n=107 Participants
19 Participants
n=206 Participants
Race/Ethnicity, Customized
Other
0 Participants
n=99 Participants
1 Participants
n=107 Participants
1 Participants
n=206 Participants
Region of Enrollment
United States
12 Participants
n=99 Participants
14 Participants
n=107 Participants
26 Participants
n=206 Participants
Response to Cold Testing
Negative Response to Cold Testing at Baseline
2 Participants
n=99 Participants
4 Participants
n=107 Participants
6 Participants
n=206 Participants
Response to Cold Testing
Positive Response to Cold Testing at Baseline
10 Participants
n=99 Participants
10 Participants
n=107 Participants
20 Participants
n=206 Participants

PRIMARY outcome

Timeframe: Within 10 minutes of injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Perceived pain on injection, self-reported verbally using a Likert scale from 1-10, with lower numbers corresponding to less pain (1 = "no pain," 10 = "worst pain imaginable"). Lower scores reflect a lesser degree of pain.

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Mean Pain Scores Following Injection
3.0 score on a scale
Standard Deviation 1.9
3.3 score on a scale
Standard Deviation 1.5

PRIMARY outcome

Timeframe: Up to 30 minutes following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Time in minutes beginning immediately following injection to patient-reported lip numbness

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Mean Time to Lower Lip Numbness Following Injection
3.4 minutes
Standard Deviation 1.3
4.4 minutes
Standard Deviation 3.7

PRIMARY outcome

Timeframe: One blood draw taken 15 minutes following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Blood Lidocaine Level (mcg/mL) as measured in 10cc venous blood, taken 15 minutes following injection. Blood assayed for serum lidocaine levels with a Sciex TripleTOF liquid chromatography- mass spectrometry (LC-MS) equipped with a C18 Hypersil (10mm x 2.1mm, 3.0μm).

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Average Serum Lidocaine Concentration at 15 Minutes Post Injection
243.5 mcg/ml
Standard Deviation 127.9
600.2 mcg/ml
Standard Deviation 497.0

PRIMARY outcome

Timeframe: Within 24 hours following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Response in minutes from injection to when lip is no longer numb, as self reported by patient.

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Mean Time to Baseline Lip Sensation
218 minutes
Standard Deviation 59.6
241 minutes
Standard Deviation 91.4

PRIMARY outcome

Timeframe: 5 minutes prior to injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Response to experiencing sensation to cold stimulus on permanent molar tooth prior to injection

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) Prior to Injection
Negative Response to Cold Testing at Baseline
6 Participants
2 Participants
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) Prior to Injection
Positive Response to Cold Testing at Baseline
19 Participants
23 Participants

PRIMARY outcome

Timeframe: 30 minutes following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Response to experiencing sensation to cold stimulus on permanent molar tooth 30 minutes following injection

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 30 Minutes Following Injection
Negative Response to Cold Testing
17 Participants
18 Participants
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 30 Minutes Following Injection
Positive Response to Cold Testing
8 Participants
7 Participants

PRIMARY outcome

Timeframe: 60 minutes following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Response to experiencing sensation to cold stimulus on permanent molar tooth 60 minutes following injection

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 60 Minutes Following Injection
Negative Response to Cold Testing
17 Participants
18 Participants
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 60 Minutes Following Injection
Positive Response to Cold Testing
8 Participants
7 Participants

PRIMARY outcome

Timeframe: 90 minutes following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Response to experiencing sensation to cold stimulus on permanent molar tooth 90 minutes following injection

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 90 Minutes Following Injection
Negative Response to Cold Testing
15 Participants
18 Participants
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 90 Minutes Following Injection
Positive Response to Cold Testing
10 Participants
7 Participants

PRIMARY outcome

Timeframe: 120 minutes following injection

Population: One participant did not complete the second intervention and was excluded from the data analysis.

Response to experiencing sensation to cold stimulus on permanent molar tooth 120 minutes following injection

Outcome measures

Outcome measures
Measure
Buffered Anesthetic
n=25 Participants
Subjects being administered the Buffered Anesthetic received an injection with 3cc 1% Buffered Lidocaine 1:100,000 Epinephrine. for a single IAN block using the Halstead technique. 1% Buffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 1% Buffered Lidocaine (30mg) 1:100,000 Epinephrine using the Halstead technique.
Unbuffered Anesthetic
n=25 Participants
Subjects being administered the Unbuffered Anesthetic received an injection with 3cc of 2% Unbuffered Lidocaine with 1:100,000 Epinephrine for a single IAN block using the Halstead technique. 2% Unbuffered Lidocaine 1:100,000 Epinephrine: A single IAN block with 3cc 2% Unbuffered Lidocaine (60mg) 1:100,000 Epinephrine using the Halstead technique.
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 120 Minutes Following Injection
Negative Response to Cold Testing
13 Participants
19 Participants
Number of Participants Who Respond to Cold Stimulus (Positive/Negative) 120 Minutes Following Injection
Positive Response to Cold Testing
12 Participants
6 Participants

Adverse Events

Buffered Anesthetic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Unbuffered Anesthetic

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jessica Lee, DDS, MPH, PhD

University of North Carolina at Chapel Hill

Phone: 9195373955

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place